Industry Perspectives
| 5 min read
Innovations in mass spectrometry are driving faster and more efficient drug discovery.
| 4 min read
A new imaging-guided sample preparation approach enables unbiased identification of all proteins within precisely defined tissue regions, expanding opportunities for drug discovery.
| 2 min read
The state-of-the-art facility will deliver CGMP plasmid DNA development and manufacturing services by late 2025.
| 4 min read
A new platform may finally unlock the rules behind molecular glue degraders, turning chance discoveries into programmable therapeutics.
| 5 min read
Methylation profiling of cell-free DNA is opening new possibilities for detecting cancer at its earliest, pre-symptomatic stages, offering a potential breakthrough in how and when disease is found.
| 2 min read
New funding will support scaling, team expansion, and the launch of customizable solutions for spatial biology, proteomics, and single-cell analysis.
| 4 min read
A well-chosen CDx development partner can streamline drug development, reduce delays, and pave the way for successful regulatory approval and market entry.
| 4 min read
For rare and inherited kidney diseases, genetic testing is solving the clinical trial recruitment crisis and reshaping how precision therapies get to patients.
| 1 min read
New confocal fluorescence imaging minimizes photobleaching and phototoxicity effects, capturing clear images of live 3D culture
| 2 min read
The new DMF gives developers a faster, simpler path to advance their cell therapy programs using trusted, clinical-grade starting materials.
| 2 min read
Simtra is positioned to become the first CDMO to offer commercial-scale drug product manufacturing of ADCs in the US, enabling customers to complete the entire supply chain domestically.
| 2 min read
The ABX-01 is a broad-spectrum antimicrobial specifically selected to combat clinically prevalent and multidrug-resistant bacterial strains.
